Advertisement
Screener

Eagle Pharmaceuticals, Inc. Form DEFA14A: Additional definitive proxy soliciting materials

Eagle Pharmaceuticals, Inc. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-05-01: Form DEFA14A; Description DEFA14A; Document tm2314210d3_defa14a.htm.
  • 2022-06-15: Form DEFA14A; Description DEFA14A; Document tm2218378d2_defa14a.htm.
  • 2021-04-30: Form DEFA14A; Description DEFA14A; Document tm212442d2_defa14a.htm.
  • 2020-05-22: Form DEFA14A; Description DEFA14A; Document a20-20634_1defa14a.htm.
FiledFormPeriod of reportDescriptionDocument
2023-05-01DEFA14ADEFA14Atm2314210d3_defa14a.htm
2022-06-15DEFA14ADEFA14Atm2218378d2_defa14a.htm
2021-04-30DEFA14ADEFA14Atm212442d2_defa14a.htm
2020-05-22DEFA14ADEFA14Aa20-20634_1defa14a.htm
2020-04-29DEFA14ADEFA14Aa20-2075_3defa14a.htm
2019-04-30DEFA14ADEFA14Aa19-2654_3defa14a.htm
2018-04-30DEFA14ADEFA14Aa18-3096_3defa14a.htm
2017-04-28DEFA14ADEFA14Aa17-11998_3defa14a.htm
2015-06-25DEFA14ADEFA14Aa2225252zdefa14a.htm